Niramai’s AI innovation: A game changer in breast cancer detection

October 22, 2025 Innovation Valli Sarvani

Breast cancer remains one of the leading causes of cancer deaths among women, and early detection is crucial for survival.

However, for women with dense breast tissue, which affects nearly 40-50% of women, traditional mammograms often fail to detect tumours early.

This gap in screening accuracy has serious consequences, but an Indian innovation is changing that.

Niramai Health Analytix, founded by Dr Geetha Manjunath, has developed Thermalytix.

This revolutionary breast cancer screening tool uses artificial intelligence and thermal imaging to detect abnormalities in breast tissue, even in dense breasts where mammograms often miss tumours.

Unlike mammograms, Thermalytix is radiation-free, non-invasive, and completely pain-free.

It works by capturing thermal images of the breast and using AI to analyse heat patterns and vascular changes that indicate early signs of cancer.

This method allows detection of cancers at stage 0 or 1, often before any physical symptoms appear.

Clinical studies show Thermalytix has a false negative rate of less than 5%, compared to up to 50% in mammograms for women with dense breast tissue.

This high level of accuracy makes it a reliable alternative screening method, especially where access to advanced imaging like MRIs or ultrasounds is limited.

The technology is also portable and cost-effective, making it ideal for deployment in rural areas, corporate offices, and underserved communities.

A single device can screen about 30 women per day, and results are delivered within 24 hours after being reviewed by a healthcare professional.

By removing barriers such as cost, discomfort, and access to facilities, Niramai is empowering more women to take control of their health.

Importantly, it doesn’t replace mammography but offers a powerful complementary tool, particularly for women at higher risk due to dense breast tissue.

Dr Geetha’s personal loss inspired a mission to eliminate breast cancer deaths, and Niramai’s innovation is a major step in that direction.

As this technology reaches more women, it offers not just early detection, but a real chance at survival.

Image Credit: Niramai Website Screenshot